Bipolar disorder has been classified as one of the main sources of disability and financial burden as stated by a study done by the World Health Organization in 2004. This chronic neurological disorder causes eccentric changes in mood, energy, and the competency to perform daily tasks due to frequent mood episodes, affecting the patient’s life dramatically (Buturak). According to Buturak, a medical doctor and assistant professor in the department of psychiatry at Kirikkale University Faculty of Medicine, “patients with BD bipolar disorder  have a high risk of continuing mood episodes even 40 years after inception even with treatment.” For this reason, medication and treatment are vital to prevent future manic episodes. These many methods of treatment involve the use of high-risk medications, particularly lithium, which can further alter the patient’s well-being. However, bipolar disorder that is not maintained by prescribed medication may have even more severe consequences on the patient, both physically and psychologically. As a result of extensive scientific research and examination, the diversified treatments used to medicate bipolar disorder, including psychotherapy and mood stabilizers, have proven to lead to many short and long-term neurological ramifications, reduce the increased inclination to commit suicide among bipolar disorder patients, and affect the patient’s immediate family.Suicide is a prevalent conception among the population of individuals afflicted with bipolar disorder. Bipolar disorder contains a high standardized mortality ratio, being 10 to 30 times that of the general population (Schaffer). Dr. Ayal Schaffer, head of the Mood and Anxiety Disorders Program and associate professor in the Department of Psychiatry at the University of Toronto, provides a plethora of factors associated with suicide attempts in bipolar disorder patients. Dr. Leonardo Tondo, a research associate for the International Consortium for Bipolar and Psychotic Disorders Research at McLean Hospital, also describes that many factors contribute to suicide, however, he states that “the strongest identified risk factor for suicide generally is a previous suicide attempt” (Tondo). Due to the patient’s severely altered mental state, there is an inflated risk of suicide among bipolar disorder patients compared to other psychological disorders. Various medication, particularly lithium, has been proven to significantly reduce the risk of suicide among these patients. In one study conducted in Denmark, published in the Archives of General Psychiatry, 1.2 million had been divided into groups based on who had purchased lithium during the study period. The results revealed that those who purchased lithium once had a “4.86-fold increased rate of suicide compared with those who did not purchase lithium” and a “0.43-fold reduced rate” among those who purchased the lithium treatment more than two times (Kessing). Thus, this study supports the concept that high-risk medications, such as lithium, assist in reducing the suicide rate among bipolar disorder patients. The high standardized mortality ratio caused by this chronic mood disorder is significantly lowered with the use and adherence to lithium treatment as opposed to no exposure to lithium.